Browse Guides  internal medicine  endocrine and metabolic disorders

Hypercalcaemia

Prevalence
Causes
Clinical features
Investigations
Therapy
Prevention
Prognosis
Therapy

Malignancy

Give pamidronate a 90 mg over 1 hour intravenously a

Why?

  • It speeds return to normocalcaemia and reduces relapse a  
  • Fever is a common side-effect a  
  • 90 mg of pamidronate is more effective than 30 or 60 mg a  
  • It is more effective than etidronate a , clondronate, and mithramycin a and the effects lasts longer (on average 2 weeks a  


90 mg of pamidronate helps correct hypercalcaemia and prevents relapse

Patient Treatment Comparison Outcome CER RRR
(95% CI)
NNT
(95% CI)
hypercalcaemia a pamidronate placebo normocalcaemia
at 7 days
22% -220%
(-611% to -44%)
2
(1 to 4)
      fever due to medication
at 7 days
0.0%
-5
(-10 to -3)
      relapse (following normocalcaemia )
at 7 days
91% 43%
(23% to 58%)
3
(2 to 5)
hypercalcaemia a pamidronate 90 mg iv pamidronate 60 mg iv normocalcaemia
 
100% -64%
(-137% to -13%)
3
(2 to 6)
hypercalcaemia a pamidronate etidronate normocalcaemia
at 7 days
40% -75%
(-180% to -10%)
3
(2 to 14)
hypercalcaemia a pamidronate clondronate normocalcaemia
at 7 days
80% -25%
(-56% to 0%)
5
(3 to 40)
hypercalcaemia a pamidronate mithramycin normocalcaemia
at 9 days
86% -270%
(-860% to -40%)
1
(1 to 2)

Expiry date: September 2004
Levels of Evidence used in grading these guides

Author   CM   Ball
Reviewer   S B   Ramirez
CAT Writers   CM   Ball , CJ   Wotton